Triglyceride-glucose glycemic variability index在危重不稳定心绞痛患者中的预后价值:机器学习联合独立医院验证
Prognostic value of triglyceride-glucose glycemic variability index in critically ill unstable angina patients via machine learning with independent hospital validation
对1,444例来自MIMIC-IV 3.1数据库的危重不稳定心绞痛成人患者的回顾性分析显示,较高TyG-GVI水平与ICU死亡率升高相关(HR 2.29,95% CI 1.43–3.66,n=108;ICU病死率7.5%),也与院内死亡率(n=190;住院病死率13.2%)相关,但后者未在所有模型设定中均达统计学显著。
- Article
- Open access
- Published: 15 November 2026
- Zhiguang Zheng1 na1,
- Junwei Qiu ORCID: orcid.org/0009-0008-7116-03822 na1,
- Yunru Qian2 na1,
- Shengshan Xu3,
- Yanqiu Jiang1 &
- …
- Ke-Jie He1
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
The triglyceride-glucose (TyG) index is associated with outcomes in critical illness, but the prognostic value of combining it with glycemic variability, the TyG-glycemic variability index (TyG-GVI), has not been evaluated in critically ill patients with unstable angina. In this study we examined the association between TyG-GVI and ICU and in-hospital mortality and developed an interpretable machine-learning model for mortality risk. We retrospectively analyzed 1,444 adult patients with unstable angina from the MIMIC-IV 3.1 database (2008–2022) as the development cohort, dichotomized at the median TyG‑GVI. Associations with ICU and in-hospital mortality were estimated using Cox proportional-hazards and logistic regression, and the dose-response relationship was modelled with restricted cubic splines. Random Forest, XGBoost and LightGBM classifiers were developed with Boruta confirmatory importance analysis and SHAP-based interpretation, and the optimal model was externally validated in an independent retrospective cohort of 340 ICU patients with unstable angina from the Quzhou Affiliated Hospital of Wenzhou Medical University. A total of 108 ICU deaths (7.5%) and 190 in-hospital deaths (13.2%) occurred. Compared with the low TyG-GVI group, high TyG-GVI was associated with ICU mortality in the fully adjusted Cox model (HR 2.29, 95% CI 1.43–3.66) and with in-hospital mortality (HR 1.54, 95% CI 1.11–2.15), although the latter did not reach statistical significance in every model specification. The dose-response relationship was non-linear (P for non-linearity < 0.01 for ICU mortality and < 0.05 for in-hospital mortality), with a data-derived nadir at a TyG-GVI of approximately 3.135. Random Forest achieved the numerically highest discrimination in the development cohort (AUC 0.830) and in the external validation cohort (AUC 0.874). High TyG-GVI was independently associated with ICU mortality and was also associated with in-hospital mortality in critically ill patients with unstable angina. An interpretable machine-learning model incorporating TyG-GVI showed consistent discrimination performance in the development and external validation cohorts and has been deployed as a web-based research prototype. Prospective validation and formal assessment of calibration and clinical utility are required before clinical use.
Abbreviations
- AUC:
-
Area under the receiver operating characteristic curve
- BIDMC:
-
Beth Israel Deaconess Medical Center
- CI:
-
Confidence interval
- CV:
-
Coefficient of variation
- DCA:
-
Decision curve analysis
- GVI:
-
Glycemic variability index
- ICU:
-
Intensive care unit
- MIMIC-IV:
-
Medical Information Mart for Intensive Care IV
- ML:
-
Machine learning
- NPV:
-
Negative predictive value
- OASIS:
-
Oxford Acute Severity of Illness Score
- PPV:
-
Positive predictive value
- RCS:
-
Restricted cubic spline
- RF:
-
Random Forest
- SAPS II:
-
Simplified Acute Physiology Score II
- SHAP:
-
SHapley Additive exPlanations
- TyG:
-
Triglyceride-glucose
- UA:
-
Unstable angina
Acknowledgements
The authors wish to acknowledge no additional contributions for this manuscript.
Funding
This project was funded by National Nature Science Foundation of China (No: 82505254); Technology Project of Zhejiang Provincial Health Commission (No: 2025KY1779); Quzhou Municipal Science and Technology Bureau (No: 2023K117).
Author information
Author notes
Zhiguang Zheng, Junwei Qiu and Yunru Qian contributed equally to this work.
Authors and Affiliations
The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, China
Zhiguang Zheng, Yanqiu Jiang & Ke-Jie He
School of Integrated Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
Junwei Qiu & Yunru Qian
Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen, Guangdong, China
Shengshan Xu
Authors
- Zhiguang Zheng
- Junwei Qiu
- Yunru Qian
- Shengshan Xu
- Yanqiu Jiang
- Ke-Jie He
Corresponding author
Correspondence to Ke-Jie He.
Ethics declarations
Consent for publication
Not applicable.
Ethics approval and consent to participate
The MIMIC-IV database was approved by the institutional review boards of the Massachusetts Institute of Technology and the Beth Israel Deaconess Medical Center, with a waiver of informed consent owing to de-identification. The external cohort was approved by the Institutional Review Board of the Quzhou Affiliated Hospital of Wenzhou Medical University (approval No. 2026-074), which waived the requirement for written informed consent. All methods were performed in accordance with the Declaration of Helsinki and relevant institutional regulations. This retrospective study utilized anonymized public epidemiological data derived from the MIMIC database as well as de-identified retrospective patient data from our hospital. All patient information was anonymized to protect individual privacy, with no identifiable personal data included. Given the retrospective design and fully anonymized nature of the data, ethical approval and written informed consent from patients were exempted by our institutional ethics committee. Thus, formal ethical approval and individual informed consent were not required for this study.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Zheng, Z., Qiu, J., Qian, Y. et al. Prognostic value of triglyceride-glucose glycemic variability index in critically ill unstable angina patients via machine learning with independent hospital validation. Sci Rep (2026). https://doi.org/10.1038/s41598-026-79521-y
Received: 04 September 2026
Accepted: 31 October 2026
Published: 15 November 2026
DOI: https://doi.org/10.1038/s41598-026-79521-y
Keywords
来源:Nature 健康护理主题 · nature.com